Business of bioanalysis: Scott Summerfield, GlaxoSmithKline

Having studied for a PhD and post doctoral fellowship in proteomics Scott moved into the field of regulated Bioanalysis in 1997 when joining SmithKline Beecham.  In 2001 Scott moved to Neuroscience Drug Discovery to lead a bioanalytical team supporting PK, in vitro DMPK and metabolite id work. In 2009 he returned to the regulated bioanalytical group, initially as a Section Leader and subsequently as Site Head and currently as WW Head of Bioanalysis at GSK ((Brentford, UK).
Scott has experience of small molecule bioanalysis as well as leading both bioanalytical discovery and development project teams across GSK.


Click here to go back to the Business of bionanalysis: season 2 homepage!